(Q44389356)

2 December 2017

title

Polyol pathway and protein kinase C activity of rat Schwannoma cells (English)

1 reference

protein kinase C activity

2 December 2017

main subject

1 reference

8

Nigishi Hotta

1 reference

2 December 2017

Hideki Kamiya

1

1 reference

2 December 2017

Jiro Nakamura

2

1 reference

2 December 2017

Yoji Hamada

3

1 reference

2 December 2017

Eitaro Nakashima

4

1 reference

2 December 2017

Keiko Naruse

5

1 reference

2 December 2017

Koichi Kato

6

1 reference

2 December 2017

Yutaka Yasuda

7

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Diabetes - Metabolism: Research and Reviews

2 December 2017

published in

1 reference

2 December 2017

volume

19

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

131-139

1 reference

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

2 December 2017

cites work

1 reference

Aldose reductase inhibitors and diabetic complications

21 January 2018

1 reference

7 January 2021

Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage

1 reference

7 January 2021

Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats

1 reference

7 January 2021

Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

1 reference

7 January 2021

Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor

1 reference

7 January 2021

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

1 reference

7 January 2021

Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy

1 reference

7 January 2021

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

7 January 2021

1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats

1 reference

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

7 January 2021

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

1 reference

7 January 2021

Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells

1 reference

7 January 2021

Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity

1 reference

7 January 2021

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

7 January 2021

A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats

1 reference

7 January 2021

Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma cells.

1 reference

7 January 2021

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

1 reference

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

7 January 2021

A synthetic peptide substrate for selective assay of protein kinase C

1 reference

7 January 2021

Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute str

1 reference

7 January 2021

Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy

1 reference

7 January 2021

Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats

1 reference

7 January 2021

Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism

1 reference

7 January 2021

The potential for isoenzyme-selective modulation of protein kinase C.

1 reference

7 January 2021

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

1 reference

7 January 2021

Regulation of protein kinase C and role in cancer biology.

1 reference

7 January 2021

Protein kinase C-alpha regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells

1 reference

7 January 2021

Antisense oligonucleotides targeted against protein kinase c alpha inhibit proliferation of cultured avian myoblasts.

1 reference

7 January 2021

MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype

1 reference

7 January 2021

An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.354

1 reference

2 December 2017

1 reference